Drugmaker Lantheus has completed its acquisition of radiopharmaceutical firm Evergreen Theragnostics in a deal valued at up to $1 billion.The North Billerica, Massachusetts-based buyer announced the deal’s closing on Tuesday after scoring the necessary regulatory approvals. Founded in 2019 and headquartered in Springfield, New Jersey, Evergreen develops and manufactures imaging agents for diagnosing and treating […]
